Alkem Laboratories
Logotype for Alkem Laboratories Limited

Alkem Laboratories (ALKEM) investor relations material

Alkem Laboratories Investor Day Presentation summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Alkem Laboratories Limited
Investor Day Presentation summary18 Feb, 2026

Strategic direction and market opportunity

  • Expansion into MedTech aligns with sector growth, targeting a $680B global market projected to reach $870B by 2030, with India’s market expected to nearly double by 2030.

  • Focus on high-growth, high-margin segments: orthopedics (knee and hip implants) and cardiovascular devices, leveraging innovation and cost-competitive manufacturing.

  • Government policies and rising insurance penetration in India support sector growth and localization, reducing import dependency.

  • Emphasis on recurring revenue through strong customer loyalty and a consolidated industry structure.

Business development and execution

  • Hybrid approach in orthopedics: organic growth via tech transfer and asset acquisition, with state-of-the-art manufacturing and a five-year vision to reach 250,000+ implants and 10% market share in India.

  • Cardiovascular entry driven by acquisition and portfolio expansion, targeting structural heart and closure devices, with a focus on global market access.

  • Acquisition of a 51-55% stake in Occlutech Holding AG for €180.7M, funded by internal accruals, expected to close by June 2026.

  • Occlutech brings a strong global presence, robust R&D, and a complete portfolio of minimally invasive cardiac devices, with 200,000+ implants sold and 14% CAGR (2021-25).

Financial guidance and future outlook

  • Acquisition expected to enhance global reach, operational excellence, and product innovation, leveraging synergies for value creation.

  • High EBITDA margins anticipated for scaled Indian players operating globally, with continuous management initiatives to optimize the business model.

  • Regulatory approvals for new products (knee, hip, and cardiac devices) targeted between Q4 FY27 and Q4 FY28, supporting international expansion.

  • Commitment to building a comprehensive, high-quality MedTech portfolio and a strong ecosystem through vertical integration and skill development.

Occlutech's path to grow US market share from 2%
Ortho vs. Cardio: How do growth strategies differ?
Implications of Ortho CE/CIS approval timelines
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Alkem Laboratories earnings date

Logotype for Alkem Laboratories Limited
Q4 25/2626 May, 2026
Alkem Laboratories
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Alkem Laboratories earnings date

Logotype for Alkem Laboratories Limited
Q4 25/2626 May, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Alkem Laboratories Limited is a pharmaceutical company engaged in the development, manufacturing, and marketing of generic and branded medicines. The company’s product portfolio spans multiple therapeutic areas, including anti-infectives, gastroenterology, cardiology, neurology, and pain management. It operates a network of research and manufacturing facilities to supply domestic and international markets. The company is headquartered in Mumbai, India, and its shares are listed on the Bombay Stock Exchange (BSE) and the National Stock Exchange of India (NSE).

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage